Global Calcium Gluconate Market
Pharmaceuticals

Calcium Gluconate Market to Reach $162.69 Billion by 2029 | Key Drivers and Future Outlook

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Estimated Market Size of the Calcium Gluconate Market In 2029?

The market size for calcium gluconate has been expanding robustly over the past few years. The market is predicted to rise from $110.12 billion in 2024 to $119.38 billion in 2025, registering a compound annual growth rate (CAGR) of 8.4%. The escalating growth in the historical timeframe is credited to factors such as economic prosperity and industrialization, higher utilization of calcium gluconate in functional foods, a surge in demand for pharmaceuticals and dietary supplements, increasing recognition of calcium deficiency issues, and regulatory endorsement for food additives.

What Growth Rate Is Forecasted for the Calcium Gluconate Market by 2029?

Expectations of robust expansion are slated for the calcium gluconate market over the coming years, with projections placing its value at $162.69 billion in 2029, a figure reflecting a compound annual growth rate (CAGR) of 8.0%. This forecasted growth can be concretely linked to various factors such as a surge in the elderly population alongside amplified health awareness, growth in the food and beverage sector, application of digital marketing and e-commerce for product visibility, a shift towards organic and naturally-derived products along with emerging markets, and fast-paced urbanization. Key trends set to define the forecast period include healthcare research and development centered around eco-friendly sourcing and production, the integration of calcium gluconate into medical protocols, tailored formulations specific to individual health demands, and evolutionary advancements in manufacturing techniques.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16005&type=smp

Which Key Companies Are Shaping the Future of the Calcium Gluconate Market?

Major companies operating in the calcium gluconate market are Merck & Co. Inc., Thermo Fisher Scientific Inc., Abbott Laboratories, Novartis AG, Eli Lilly and Company, Solvay, Viatris Inc., Baxter International Inc., Fresenius Kabi USA, Hikma Pharmaceuticals Inc., Amneal Pharmaceuticals Private Limited, Amphastar Pharmaceuticals, Jost Chemical Co., American Regent Inc., Coyne Chemical, Anhui Xingzhou Medicine Food Co. Ltd., Westco Chemicals Inc., Noah chemicals, ND Biotech Pvt Ltd, Global Calcium Private Limited, Foodchem, Pharma Cure Laboratories, Nivagen Pharmaceuticals Inc., Tianyi Food Additives Co. Ltd

Which Factors Are Driving Demand in the Calcium Gluconate Industry?

The calcium gluconate market is anticipated to grow due to the increasing prevalence of osteoporosis, a health issue characterized by bone frailty resulting from loss of bone density and strength. This condition often arises from inactive lifestyles, insufficient calcium intake, hormonal shifts, and certain medications or health conditions. In managing osteoporosis, calcium gluconate steps in to augment the consumption of dietary calcium and bolster bone wellness. As per the Australian Institute of Health and Welfare (AIHW) in December 2023, osteoporosis attributed to 2,366 deaths, equivalent to a death rate of 6.5 per 100,000 individuals and represented 1.4% of the total deaths in 2022. In the same year, osteoporosis accounted for 9,500 hospital admissions, equating to 89 admissions per 100,000 populace for those aged 45 and above. Consequently, the escalating osteoporosis cases are stimulating the expansion of the calcium gluconate market. The ascent in healthcare expenditure is another factor predicted to boost the calcium gluconate market. Healthcare pertains to the systematic arrangement of medical care, facilities, health experts, and resources committed to enhancing, sustaining, and recovering the physical and mental health of the population. The healthcare expenditure surge arises from aging populations, increasing instances of chronic illnesses, medical technology advancements, and escalating preference for superior healthcare services. In the healthcare landscape, calcium gluconate is chiefly deployed to remedy conditions instigated by deficient calcium levels like hypocalcemia, cardiac arrest, and specific kinds of toxicity. For instance, future economic predictions from the UK’s Office for Budget Responsibility (OBR) and the Treasury indicate health spending in the UK is slated to grow from £182 billion ($231.70 billion) in 2022/23 to £192 billion ($244.43 billion) in 2024/25. Therefore, this escalation in healthcare expenditure is propelling the calcium gluconate market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16005&type=smp

How Is the Calcium Gluconate Market Segmented by Several Divisions?

The calcium gluconate market covered in this report is segmented –

1) By Form: Liquid, Tablet, Powder, Gel

2) By Grade: Pharmaceutical Grade, Food Grade

3) By Application: Food And Beverage Manufacturers, Pharmaceutical, Nutraceutical, Cosmetic And Personal Care, Other Applications

4) By End Use: Emulsifier, Bulking Agent, Thickening Agent

Subsegments:

1) By Liquid: Injectable Solution, Oral Liquid, IV Infusion

2) By Tablet: Standard Tablets, Effervescent Tablets

3) By Powder: Oral Powder, Injectable Powder

4) By Gel: Topical Gel, Transdermal Gel

What are the Emerging Market Trends Driving the Growth of the Calcium Gluconate Industry?

Leading businesses in the calcium gluconate market are concentrating their efforts on the development and regulatory approval of calcium gluconate medicines, with the aim of expanding their portfolio of effective treatments for calcium deficiencies and associated health issues. The development and approval of any new drug is a intricate multi-step procedure, encompassing everything from initial drug discovery and preclinical testing to clinical trials and ultimate regulatory approval for marketing. As an example, in September 2023, Amneal Pharmaceuticals Inc., a publicly traded American company specializing in generic and specialty pharmaceuticals, was granted approval for their abbreviated new drug application (ANDA) for calcium gluconate in sodium chloride injection by the U.S. Food and Drug Administration (FDA). The product, boasting the Competitive Generic Therapy (CGT) designation and a 180-day exclusivity period, is available in compositions of 1000 mg/50 mL and 2000 mg/100 ml and serves as a small-volume parenteral bag designed to tackle acute symptomatic hypocalcemia in both pediatric and adult patients.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/calcium-gluconate-global-market-report

Which Regions Are Driving Growth in the Calcium Gluconate Market?

Europe was the largest region in the calcium gluconate market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcium gluconate market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16005

This Report Delivers Insight On:

1. How big is the calcium gluconate market, and how is it changing globally?

2. Who are the major companies in the calcium gluconate market, and how are they performing?

3. What are the key opportunities and risks in the calcium gluconate market right now?

4. Which products or customer segments are growing the most in the calcium gluconate market?

5. What factors are helping or slowing down the growth of the calcium gluconate market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model